Mission statement · Company scope
“Our mission is to make a meaningful impact on the lives of patients with cancer and high unmet medical needs by delivering novel, PRAME-directed immunotherapies that provide tangible clinical benefits.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Product offering (primary) · Problem–solution · Innovation
- Leads with
- Product
- Best for
- Climate & health
- Formula
- We make [product] for [who]
- Tone
- Plain
- Length
- 30 words · reading grade 18.6
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.74
- Record
- st_052aacf29edc1884
- Classification confidence
- 0.67
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-05 · sec_sentence · 20-F · accession 0001193125-26-092529
View filing ↗0 to compareCompare